Neurological Disorder clinical trials

Explore recruiting neurological disorder clinical trials.

Recruiting neurological disorder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neurological Disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label, Multicenter Extension Study Providing Continued Access to Treatment in Patients with a Neurological Disease Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Study and without Access to A Post Trial Access Program

Czechia, France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label, Multicenter Extension Study Evaluating the Patient Perspective of the Physical Impact of Multiple Sclerosis and Providing Continued Access to Ocrelizumab in Patients with Multiple Sclerosis Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Study and without Access to A Post Trial Access Program

France, Germany, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

RIFAMAB : Rifabutin versus rifampicin for treatment of staphylococcal prosthetic joint infection treated with debridement, antibiotics and implant retention (DAIR strategy): a multicenter randomized, open-label, non-inferiority trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neurological Disorder trials by city

Neurological Disorder in Toronto Neurological Disorder in Vancouver Neurological Disorder in Montreal Neurological Disorder in Calgary Neurological Disorder in Edmonton Neurological Disorder in Ottawa Neurological Disorder in Winnipeg Neurological Disorder in Quebec City Neurological Disorder in Hamilton Neurological Disorder in Kitchener Neurological Disorder in London Neurological Disorder in Halifax Neurological Disorder in New York Neurological Disorder in Los Angeles Neurological Disorder in Chicago Neurological Disorder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease